{
    "Trade/Device Name(s)": [
        "CareSens N Blood Glucose Monitoring System",
        "CareSens N Meter",
        "CareSens N Test Strip",
        "CareSens Control A&B Solutions"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K083468",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080923",
        "K024194"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "February 10, 2009",
    "Summary Letter Received Date": "January 26, 2009",
    "Submission Date": "January 26, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CareSens N Meter (Model GM505IA, GM505IB, GM505IC)"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase enzymatic reaction",
        "Amperometric method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for CareSens N Blood Glucose Monitoring System measuring glucose via amperometric glucose oxidase method with automatic code identification and user interface enhancements",
    "Indications for Use Summary": "Quantitative measurement of glucose in capillary whole blood as an aid in monitoring diabetes management at home or in clinical settings; in vitro diagnostic use only; not for diagnosis or screening of diabetes",
    "fda_folder": "Clinical Chemistry"
}